Latest Market Segmentation News

Peter Warren Automotive Holdings signals a stronger finish to FY25 with an expected $22 million underlying profit, driven by strategic marketing and cost efficiencies. Investors await the full results due in August.

EVE Health Group has placed its first commercial purchase order for Dyspro™, a cannabinoid-based pharmaceutical targeting painful menstruation, signaling a key step toward market entry. The product is set for manufacturing and distribution within weeks, tapping into a rapidly growing global women’s health market.

Vitasora Health has secured approximately A$11 million in capital to accelerate its expansion in the US remote patient monitoring market, highlighted by an upgraded contract with TPAC covering 15,000 patients. The company targets a USD 18 million annual recurring revenue run-rate by late 2026.

First Graphene Limited has secured two significant orders totaling approximately A$165,000 for its PureGRAPH graphene products, signaling growing market acceptance and supporting its FY25-26 sales outlook.

State Street Global Advisors has announced a 21.5897 cents per unit cash distribution for the SPDR S&P/ASX Small Ordinaries ETF for the period ending June 30, 2025, alongside franking and foreign tax credits.

DXN Limited has secured a $1.6 million contract with Ventia to deploy its innovative StructCore prefabricated indoor data centre solution for a major Australian telecommunications provider, marking a strategic expansion into a new market segment.

RLF AgTech has secured exclusive rights to distribute AXIOMA Biologicals’ advanced biostimulant products across Australia, China, and Asia, marking a strategic move into the biologicals market segment.

Mesoblast reports positive FDA progress on accelerated approval for Revascor in ischemic heart failure and plans a pivotal trial to extend Ryoncil’s label to adults with graft versus host disease, while its US commercial launch outpaces expectations.

Treasury Wine Estates faces a pivotal shift as RNDC ends its California distribution, prompting a strategic rethink amid a slightly lowered FY25 EBIT forecast.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

Sprintex has commissioned an upgraded manure processing system with Mest Water, setting the stage for a major trial at Van Drie Group farms that could unlock A$8.4 million in revenue. The company is also expanding its market reach with a new mobile system targeting smaller farms amid tightening EU ammonia regulations.

Origin Energy has refined its FY25 earnings forecast, buoyed by strong wholesale performance but tempered by Octopus Energy's UK weather-related losses. Despite setbacks, Octopus continues to expand its retail footprint.